Adiponectin - A key adipokine in the metabolic syndrome

Diabetes, Obesity and Metabolism

Volumn 8, Issue 3, 2006, Pages 264-280

  Whitehead, J P ^a   Richards, A A ^a   Hickman, I J ^a   Macdonald, G A ^a   Prins, J B ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adipokine; Adiponectin; Inflammation; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVATED PROTHROMBIN COMPLEX; ADENOSINE PHOSPHATE; ADIPOCYTOKINE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; C REACTIVE PROTEIN; CADHERIN; COMPLEMENTARY DNA; DEXAMETHASONE; ENDOTHELIN 1; GLUCOCORTICOID; GLUCOSE; INSULIN; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; TRANSCRIPTION FACTOR FOXO; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; BODY FAT DISTRIBUTION; BROWN ADIPOSE TISSUE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FATTY LIVER; GENETIC ANALYSIS; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID OXIDATION; LIPOGENESIS; METABOLIC SYNDROME X; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; RECEPTOR BLOCKING; REVIEW; SKELETAL MUSCLE; SMOOTH MUSCLE; VASCULAR DISEASE;

EID: 33645501804     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00510.x     Document Type: Review

References (113)

1. Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432
2. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746 -26749. 26746-26749
3. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-10703.
4. Maeda K, Okubo K, Shimomura I et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286-289
5. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 1996; 120: 803 -812.
6. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
7. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
8. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935
9. Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth. relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004; 27: 547-552.
10. Goldstein BJ, Scalia R. Adiponectin. A Novel Adipokine Linking Adipocytes and Vascular Function. J Clin Endocrinol Metab 2004; 89: 2563-2568.
11. Nawrocki AR, Scherer PE. The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation. Curr Opin Pharmacol 2004; 4: 281-289
12. Haluzik M, Parizkova J, Haluzik MM. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 2004; 53: 123-129.
13. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 2004; 344: 1-12.
14. Zhang Z, Henzel WJ. Signal peptide prediction based on analysis of experimentally verified cleavage sites. Protein Sci 2004; 13: 2819-2824
15. Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 1998; 8: 335-340.
16. Pajvani UBX, Combs TP et al. Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 2003; 278: 9073 -9085.
17. Tsao T-S, Tomas E, Murrey HE et al. Role of Disulfide Bonds in Acrp30/ Adiponectin Structure and Signaling Specificity: Different oligomers activate different signal transduction pathways. J Biol Chem 2003; 278: 50810-50817.
18. Waki H, Yamauchi T, Kamon J et al. Impaired multimerization of human adiponectin mutants associated with diabetes: Molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278: 40352-40363
19. Wang Y, Xu A, Knight C, Xu LY, Cooper GJS. Hydroxylation and Glycosylation of the Four Conserved Lysine Residues in the Collagenous Domain of Adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem 2002; 277: 19521-19529
20. Wang Y, Lu G, Wong WP et al. Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum. Proteomics 2004; 4: 3933-3942
21. Sato C, Yasukawa Z, Honda N, Matsuda T, Kitajima K. Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue-specific glycoprotein, adipo Q. J Biol Chem 2001; 28849-28856.
22. Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 2002; 277: 29359-29362
23. Zhang Y, Matheny M, Zolotukhin S, Tumer N, Scarpace PJ. Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: Influence of beta 3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim Biophys Acta 2002; 1584: 115-122.
24. Pajvani UB, Hawkins M, Combs TP et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione -mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 12152-12162
25. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-2282.
26. Motoshima H, Wu X, Sinha MK et al. Differential Regulation of Adiponectin Secretion from Cultured Human Omental and Subcutaneous Adipocytes: Effects of Insulin and Rosiglitazone. J Clin Endocrinol Metab 2002; 87: 5662-5667.
27. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003; 52: 1779-1785.
28. Cnop M, Havel PJ, Utzschneider KM et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46: 459-469
29. Combs TP, Berg AH, Rajala MW et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003; 52: 268-276
30. Yoda-Murakami M, Taniguchi M, Takahashi K et al. Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver. Biochem Biophys Res Commun 2001; 285: 372-377.
31. Kaser S, Moschen A, Cayon A et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 2005; 54: 117-121.
32. Staiger H, Kausch C, Guirguis A et al. Induction of adiponectin gene expression in human myotubes by an adiponectin-containing HEK293 cell culture supernatant. Diabetologia 2003; 46: 956-960
33. Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM. Induction of adiponectin in skeletal muscle by inflammatory cytokines: In vivo and in vitro studies. Endocrinology 2004; 145: 5589-5597.
34. Berner HS, Lyngstadaas SP, Spahr A et al. Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004; 35: 842-849.
35. Park S-k, Oh S-Y, Lee M-Y et al. CCAAT/enhancer binding protein nuclear factor-y regulate adiponectin gene expression adipose tissue. Diabetes 2004; 53: 2757-2766
36. Gavrila A, Peng CK, Chan JL et al. Diurnal and ultradian dynamics of serum adiponectin in healthy men: Comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metab 2003; 88: 2838-2843.
37. Calvani M, Scarfone A, Granato L et al. Restoration adiponectin pulsatility severely obese subjects after weight loss. Diabetes 2004; 53: -947. 939-947
38. Yang WS, Lee WJ, Funahashi T et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815-3819
39. Berg AH, Du Combs TPX, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7: 947-953
40. Imbeault P, Pomerleau M, Harper ME, Doucet E. Unchanged fasting and postprandial adiponectin levels following a 4-day caloric restriction in young healthy men. Clin Endocrinol (Oxf) 2004; 60:429-433
41. Abbasi F, Chu JW, Lamendola C et al. Discrimination between obesity insulin resistance relationship with adiponectin. Diabetes 2004; 53: 585-590
42. Kotani Y, Yokota I, Kitamura S et al. Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clin Endocrinol (Oxf) 2004; 61: 418-423.
43. Stefan N, Bunt JC, Salbe AD et al. Plasma adiponectin concentrations in children: Relationships with obesity and insulinemia. J Clin Endocrinol Metab 2002; 87: 4652-4656
44. Bogan JS, Lodish HF. Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4. J Cell Biol 1999; 146: 609-620
45. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002; 290: 1084-1089
46. Halleux CM, Takahashi M, Delporte ML et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 2001; 288: 1102-1107.
47. Maeda N, Takahashi M, Funahashi T et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50: 2094-2099
48. Maeda N, Shimomura I, Kishida K et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731-737.
49. Fasshauer M, Kralisch S, Klier M et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003; 301: 1045-1050
50. Clarke KJ, Zhong Q, Schwartz DD et al. Regulation of adiponectin secretion by endothelin-1. Biochem Biophys Res Commun 2003; 312: 945-949
51. Phillips SA, Ciaraldi TP, Kong AP et al. Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy. Diabetes 2003; 52: 667-674.
52. Tiikkainen M, Hakkinen A-M, Korsheninnikova E et al. Effects of Rosiglitazone and Metformin on Liver Fat Content, Hepatic Insulin Resistance, Insulin Clearance, and Gene Expression in Adipose Tissue in Patients With Type 2 Diabetes. Diabetes 2004; 53: 2169-2176.
53. Combs TP, Wagner JA, Berger J et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: A potential mechanism of insulin sensitization. Endocrinology 2002; 143: 998 -1007.
54. Tonelli J, Li W, Kishore P et al. Mechanisms early insulin-sensitizing effects thiazolidinediones type 2 diabetes. Diabetes 2004; 53: 1621-1629
55. Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946
56. Iwaki M, Matsuda M, Maeda N et al. Induction of adiponectin, a fat-derived antidiabetic antiatherogenic factor, by nuclear receptors. Diabetes 2003; 52: 1655-1663
57. Kobayashi H, Ouchi N, Kihara S et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004; 94: 27-31
58. Kamon J, Yamauchi T, Muto S et al. A novel IKK[beta] inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance. Biochem Biophys Res Comms 2004; 323: 242-248.
59. Hogg PJ. Disulfide bonds as switches for protein function. Trends Biochem Sci 2003; 28: 210-214.
60. Fruebis J, Tsao TS, Javorschi S et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98: 2005-2010
61. Waki H, Yamauchi T, Kamon J et al. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 2004; 146:. 790-796.
62. Koshimura J, Fujita H, Narita T et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Comms 2004; 316: 165-169
63. Tschritter O, Fritsche A, Thamer C et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003; 52: 239-243.
64. Hotta K, Funahashi T, Bodkin NL et al. Circulating Concentrations of the Adipocyte Protein Adiponectin Are Decreased in Parallel With Reduced Insulin Sensitivity During the Progression to Type 2 Diabetes in Rhesus Monkeys. Diabetes 2001; 50: 1126-1133.
65. Spranger J, Kroke A, Mohlig M et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226-228.
66. Kissebah AH, Sonnenberg GE, Myklebust J et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 2000; 97: 14478-14483
67. Vionnet N, Hani El H, Dupont S et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000; 67: 1470-1480
68. Hara K, Boutin P, Mori Y et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51: 536-540.
69. Vasseur F, Helbecque N, Dina C et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11: 2607-2614.
70. Gu HF, Abulaiti A, Ostenson CG et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes 2004; 53 (Suppl. 1): S31-S35.
71. Gibson F, Froguel P. Genetics of the APM1 Locus and Its Contribution to Type 2 Diabetes Susceptibility in French Caucasians. Diabetes 2004; 53: 2977-2983.
72. Kondo H, Shimomura I, Matsukawa Y et al. Association of adiponectin mutation with type 2 diabetes: A candidate gene for the insulin resistance syndrome. Diabetes 2002; 51: 2325-2328.
73. Tomas E, Tsao TS, Saha AK et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 2002; 99: 16309-16313.
74. Wu X, Motoshima H, Mahadev K et al. Involvement of AMP-Activated Protein Kinase in Glucose Uptake Stimulated by the Globular Domain of Adiponectin in Primary Rat Adipocytes. Diabetes 2003; 52: 1355-1363
75. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001; 108: 1875-1881.
76. Xu A, Wang Y, Keshaw H et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003; 112: 91-100.
77. Qi Y, Takahashi N, Hileman SM et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004; 10: 524-529.
78. Kubota N, Terauchi Y, Yamauchi T et al. Disruption adiponectin causes insulin resistance neointimal formation. J Biol Chem 2002; 277: 25863-25866
79. Ma K, Cabrero A, Saha PK et al. Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem 2002; 277: 34658-34661
80. Shibata R, Ouchi N, Kihara S et al. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling. J Biol Chem 2004; 279: 28670-28674
81. Combs TP, Pajvani UB, Berg AH et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004; 145: 367-383
82. Yamauchi T, Kamon J, Ito Y et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769
83. Civitarese AE, Jenkinson CP, Richardson D et al. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 2004; 47: 816-820
84. Narasimhan ML, Coca MA, Jin J et al. Osmotin Is a Homolog of Mammalian Adiponectin and Controls Apoptosis in Yeast through a Homolog of Mammalian Adiponectin Receptor. Mol Cell 2005; 17: 171-180.
85. Tsuchida A, Yamauchi T, Ito Y et al. Insulin/foxo1 pathway regulates expression levels adiponectin receptors adiponectin sensitivity. J Biol Chem 2004; 279: 30817-30822.
86. Staiger H, Kaltenbach S, Staiger K et al. Expression of adiponectin receptor mrna in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes 2004; 53: 2195-2201
87. Fasshauer M, Klein J, Kralisch S et al. Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett 2004; 558: 27-32
88. Reseland JE, Syversen U, Bakke I et al. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 2001; 16: 1426-1433.
89. Chinetti G, Zawadski C, Fruchart JC, Staels B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPAR[alpha] PPAR[gamma] and LXR. Biochem Biophys Res Comms 2004; 314: 151-158.
90. Kharroubi I, Rasschaert J, Eizirik DL, Cnop M. Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun 2003; 312: 1118-1122
91. Hug C, Wang J, Ahmad NS et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. PNAS 2004, 0403382101.
92. Ouchi N, Kihara S, Funahashi T et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107: 671-674.
93. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: More than just another fat cell hormone? Diabetes Care 2003; 26: 2442-2450
94. Iwashima Y, Katsuya T, Ishikawa K et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43: 1318-1323
95. Ryo M, Nakamura T, Kihara S et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975-981
96. Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 2004; 27 1680-1687
97. Shimabukuro M, Higa N, Asahi T et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003; 88: 3236-3240
98. Ohashi K, Ouchi N, Kihara S et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 2004; 43: 1195-1200
99. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003; 14: 561-566
100. Okamoto Y, Kihara S, Ouchi N et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767-2770.
101. Targher G, Bertolini L, Scala L et al. Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals. Clin Endocrinol (Oxf) 2004; 61: 700-703
102. Okamoto Y, Arita Y, Nishida M et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000; 32: 47-50
103. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476
104. Ouchi N, Kihara S, Arita Y et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296-1301
105. Ouchi N, Kihara S, Arita Y et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057-1063
106. Yokota T, Oritani K, Takahashi I et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96: 1723-1732
107. Brakenhielm E, Veitonmaki N, Cao R et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 2004; 101: 2476-2481
108. Matsuda./ M, Shimomura I, Sata M et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277: 37487-37491.
109. Hui JM, Hodge A, Farrell GC et al. Beyond insulin resistance in NASH. TNF-alpha or adiponectin? Hepatology 2004; 40: 46-54.
110. Chitturi S, Abeygunasekera S, Farrell GC et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-379.
111. Shibata R, Ouchi N, Ito M et al. Adiponectin-med modulation hypertrophic signals heart. Nat Med 2004; 10: 1384-1389.
112. Yamauchi T, Kamon J, Waki H et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 2003; 278: 2461-2468.
113. Moller DE, Berger JP. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation. Int J Obes Relat Metab Disord 2003; 27 (Suppl. 3): S17-S21.